Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary D Swergold

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Atherosclerosis Reports|February 2, 2013
Potential of proprotein convertase subtilisin/kexin type 9 based therapeuticsEvan A Stein, Gary D Swergold
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2002
Tracing the LINEs of human evolutionIgor Ovchinnikov, Adrienne Rubin, Gary D Swergold
Human Genetics|March 20, 2003
Examination of sequence homology between human chromosome 20 and the mouse genome: intense conservation of many genomic elementsLingxiang Zhu, Gary D Swergold, Michael F Seldin
American Journal of Human Genetics|February 8, 2003
Large differences between LINE-1 amplification rates in the human and chimpanzee lineagesLauren M Mathews, Susan Y Chi, Noam Greenberg, et al.
The New England Journal of Medicine|March 23, 2012
Effect of a monoclonal antibody to PCSK9 on LDL cholesterolEvan A Stein, Scott Mellis, George D Yancopoulos, et al.
American Journal of Human Genetics|June 19, 2002
A comprehensive analysis of recently integrated human Ta L1 elementsJeremy S Myers, Bethaney J Vincent, Hunt Udall, et al.
Circulation. Cardiovascular Genetics|September 17, 2015
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyPaul N Hopkins, Joep Defesche, Sigrid W Fouchier, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Atherosclerosis Reports|February 2, 2013
Potential of proprotein convertase subtilisin/kexin type 9 based therapeuticsEvan A Stein, Gary D Swergold
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2002
Tracing the LINEs of human evolutionIgor Ovchinnikov, Adrienne Rubin, Gary D Swergold
Human Genetics|March 20, 2003
Examination of sequence homology between human chromosome 20 and the mouse genome: intense conservation of many genomic elementsLingxiang Zhu, Gary D Swergold, Michael F Seldin
American Journal of Human Genetics|February 8, 2003
Large differences between LINE-1 amplification rates in the human and chimpanzee lineagesLauren M Mathews, Susan Y Chi, Noam Greenberg, et al.
The New England Journal of Medicine|March 23, 2012
Effect of a monoclonal antibody to PCSK9 on LDL cholesterolEvan A Stein, Scott Mellis, George D Yancopoulos, et al.
American Journal of Human Genetics|June 19, 2002
A comprehensive analysis of recently integrated human Ta L1 elementsJeremy S Myers, Bethaney J Vincent, Hunt Udall, et al.
Circulation. Cardiovascular Genetics|September 17, 2015
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal AntibodyPaul N Hopkins, Joep Defesche, Sigrid W Fouchier, et al.
Pageof 1